DocGo Inc is primarily active in the healthcare industry.

The main competitors of DocGo Inc in the market include companies like E-Trip, MedTech Solutions, and HealthNet Innovations.

DocGo Inc is a leading company in the healthcare industry. Founded in [year], it has established itself as a trusted provider of innovative healthcare solutions. With a strong focus on improving patient outcomes, DocGo Inc offers a wide range of services including telehealth, remote patient monitoring, and medical device development. The company has a team of highly skilled professionals dedicated to delivering state-of-the-art technology and personalized care. DocGo Inc has consistently demonstrated its commitment to revolutionizing the healthcare industry, and its name has become synonymous with excellence and cutting-edge advancements in the field.

Some significant milestones achieved by DocGo Inc include the successful development and launch of their advanced medical technology solutions, which have revolutionized the healthcare industry. The company has also garnered recognition for their groundbreaking research and innovation in areas such as telemedicine, patient monitoring, and data analysis. DocGo Inc's commitment to excellence is demonstrated through their partnerships with leading healthcare organizations and the continuous improvement of their products and services. With a focus on improving patient outcomes and delivering high-quality healthcare solutions, DocGo Inc continues to make significant strides in the industry.

DocGo Inc is primarily present in multiple countries and regions around the world. Some of the key locations where DocGo Inc operates include the United States, Canada, Europe, and Asia. With a global presence, DocGo Inc has established a strong foothold in these regions, allowing them to provide their stock services and solutions to a wide range of international clients. Whether you are based in North America, Europe, or Asia, DocGo Inc is committed to delivering exceptional stock services and maintaining a strong presence in multiple countries and regions.

DocGo Inc represents a strong commitment to providing quality healthcare services through innovative technologies and a patient-centric approach. The company values include integrity, transparency, and a passion for improving healthcare outcomes. DocGo Inc strives to revolutionize the medical transportation industry by offering efficient and reliable services that prioritize patient safety and comfort. With a customer-focused philosophy, DocGo Inc aims to deliver exceptional value to both its clients and shareholders.

Analysts currently set an average price target of 2,55 USD for the DocGo stock (median: 3,06 USD), implying +290,5 % versus the latest price. The consensus is based on 12 analyst ratings.

DocGo Koersdoelstellingen analisten 2026

12 analysts currently rate the DocGo stock: 8 recommend buying, 4 holding and 0 selling. For 2026, analysts expect DocGo to generate revenue of 297,18 Miljoen USD and earnings per share of -0,31 USD.

DocGo Koersdoelstellingen analisten 2026

Converted at the current exchange rate, the DocGo share trades at 0,56 EUR (0,65 USD).

The DocGo share (DCGO) is listed on 1 stock exchanges, including: NASDAQ (DCGO).

DocGo Inc is an innovative company specialized in providing medical services through mobile health and care teams. Its business model includes various divisions and products that enable the company to effectively and efficiently meet the needs of customers and patients. One of the main divisions of DocGo Inc is the provision of medical services for patients in emergencies. This includes providing mobile intensive care units that can offer immediate medical assistance to patients in critical conditions. The teams of DocGo Inc are specially trained and equipped to act quickly and safely in any situation. This service is particularly important for patient transportation between facilities or to bridge waiting times for appointments. Another important division of DocGo Inc is telemedicine. This involves the medical care of patients through digital communication means such as phone calls, video calls, and text messages. This type of medical care is especially suitable for patients who have difficulties accessing a clinic or hospital. Additionally, it can help reduce long waiting times at the doctor's office or in the emergency room. DocGo Inc's telemedicine is easily accessible and provides a fast and reliable connection to an experienced doctor. Another product offered by DocGo Inc is mobile diagnostics. This includes conducting medical tests and examinations through mobile teams that come directly to the patient's location. This product is particularly suitable for people who have difficulties accessing a clinic or hospital but still require medical examinations. The mobile teams of DocGo Inc are specially trained and equipped with the latest medical devices and technologies. Furthermore, DocGo Inc also offers training for medical personnel and laypeople, especially those working or living in emergency situations. These trainings include courses in first aid, life-saving techniques, and medical care. These trainings are invaluable for companies and organizations that want to prepare their employees for emergencies, as well as for individuals who want to be ready to act in emergency situations. Overall, the business model of DocGo Inc is focused on providing medical services to patients quickly, reliably, and with minimal restrictions. The mobile teams of DocGo Inc are highly qualified and specially trained to act quickly and safely in any situation. The telemedicine and mobile diagnostics services are particularly suitable for patients who have difficulties accessing clinics or hospitals. Finally, DocGo Inc's trainings improve the skills of medical personnel and laypeople, ultimately saving lives in emergencies.

De verwachte omzet van DocGo bedraagt 297,18 Miljoen USD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.

De verwachte winst van DocGo bedraagt -34,32 Miljoen USD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.

De koers-winstverhouding (P/E) van DocGo bedraagt momenteel -2,06. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het DocGo-aandeel in te schatten.

De koers-omzetverhouding (P/S) van DocGo bedraagt momenteel 0,24. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het DocGo-aandeel.

De Eulerpool Kwaliteitsscore voor DocGo is 3/10.

De ISIN van DocGo is US2560861096. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.

Het tickersymbool van DocGo is DCGO. Onder dit beurstickersymbool wordt het DocGo-aandeel op de beurs verhandeld.

DocGo betaalde de afgelopen 0 jaar elk jaar dividend.

DocGo wordt toegewezen aan de sector 'Gezondheid'.

De dividenden van DocGo worden in USD uitgekeerd.